Biomedical Engineering Reference
In-Depth Information
139. Imayama S, Ueda S. Long- and short-term histological observations of
congenital nevi treated with the normal-mode ruby laser. Arch Dermatol
1999; 135: 1211-18.
140. Nanni CA, Alster TS. Treatment of a Becker's nevus using a 694-nm
long-pulsed ruby laser. Dermatol Surg 1998; 24: 1032-4.
141. Ueda S, Imayama S. Normal-mode ruby laser for treating congenital
nevi. Arch Dermatol 1997; 133: 355-9.
142. Gold MH, Foster TD, Bell MW. Nevus spilus successfully treated with an
intense pulsed light source. Dermatol Surg 1999; 25: 254-5.
143. Manuskiatti W, Fitzpatrick RE, Goldman MP. Treatment of facial skin
using combinations of CO
2
, Q-switched alexandrite, fl ashlamp-pumped
pulsed dye, and Er:YAG lasers in the same treatment session. Dermatol
Surg 2000; 26: 114-20.
144. Park SH, Koo SH, Choi EO. Combined laser therapy for diffi cult dermal
pigmentation: resurfacing and selective photothermolysis. Ann Plast
Surg 2001; 47: 31-6.
145. Momosawa A, Yoshimura K, Uchida G, et al. Combined therapy using
Q-switched ruby laser and bleaching treatment with tretinoin and
hydroquinone for acquired dermal melanocytosis. Dermatol Surg 2003;
29: 1001-7.
146. Kono T, Ercocen AR, Chan HH, et al. Effectiveness of the normal-mode
ruby laser and the combined (normal-mode plus q-switched) ruby laser
in the treatment of congenital melanocytic nevi: a comparative study.
Ann Plast Surg 2002; 49: 476-85.
147. Kono T, Ercocen AR, Kikuchi Y, et al. A giant melanocytic nevus treated
with combined use of normal mode ruby laser and Q-switched alexan-
drite laser. J Dermatol 2003; 30: 538-42.
148. Kono T, Nozaki M, Chan HH, et al. Combined use of normal mode and
Q-switched ruby lasers in the treatment of congenital melanocytic naevi.
Br J Plast Surg 2001; 54: 640-3.
149. Alster TS. Q-switched alexandrite laser treatment (755 nm) of profes-
sional and amateur tattoos. J Am Acad Dermatol 1995; 33: 69-73.
150. Fitzpatrick RE, Goldman MP. Tattoo removal using the alexandrite laser.
Arch Dermatol 1994; 130: 1508-14.
151. Kilmer SL, Anderson RR. Clinical use of the Q-switched ruby and the
Q-switched Nd:YAG (1064 nm and 532 nm) lasers for treatment of
tattoos. J Dermatol Surg Oncol 1993; 19: 330-8.
152. Zelickson BD, Mehregan DA, Zarrin AA, et al. Clinical, histologic, and
ultrastructural evaluation of tattoos treated with three laser systems.
Lasers Surg Med 1994; 15: 364-72.
153. Chang SE, Choi JH, Moon KC, et al. Successful removal of traumatic
tattoos in Asian skin with a Q-switched alexandrite laser. Dermatol Surg
1998; 24: 1308-11.
154. Grevelink JM, Duke D, van Leeuwen RL, et al. Laser treatment of tattoos
in darkly pigmented patients: effi cacy and side effects. J Am Acad
Dermatol 1996; 34: 653-6.
155. Jones A, Roddey P, Orengo I, et al. The Q-switched ND:YAG laser effec-
tively treats tattoos in darkly pigmented skin. Dermatol Surg 1996; 22:
999-1001.
156. Kilmer SL, Lee MS, Grevelink JM, et al. The Q-switched Nd:YAG laser
effectively treats tattoos. Arch Dermatol 1993; 129: 971-8.
157. Lim Y, Choi H, Myung K. Effects of treatment according to tattoo color,
site and duration with the Q-switched alexandrite laser. Kor J Dermatol
1998; 36: 844-9.
158. Suzuki H. Treatment of traumatic tattoos with the Q-switched
neodymium:YAG laser. Arch Dermatol 1996; 132: 1226-9.
159. Taylor CR, Gange RW, Dover JS, et al. Treatment of tattoos by Q-switched
ruby laser. Arch Dermatol 1990; 126: 893-399.
160. Al-Mutairi N, Manchanda Y, Almutairi L. Tattooing in the Gulf region: a
review of tattoo practices and response to treatment with the Q-switched
ruby laser. J Cosmet Laser Ther 2010; 12: 132-7.
161. Moreno-Arias GA, Casals-Andreu M, Camps-Fresneda A. Use of
Q-switched alexandrite laser (755 nm, 100 nsec) for removal of trau-
matic tattoo of different origins. Lasers Surg Med 1999; 25: 445-50.
162. Sherwood KA, Murray S, Kurban AK, et al. Effect of wavelength on cuta-
neous pigment using pulsed irradiation. J Invest Dermatol 1989; 92:
717-20.
163. Anderson RR. Laser-Tissue Interactions, 2nd edn. St. Louis: Mosby, 1999.
164. Bernstein LJ, Kauvar ANB, Grossman MC, et al. The short- and long-
term side effects of carbon dioxide laser resurfacing. Dermatol Surg
1997; 23: 519-25.
165. Manuskiatti W, Fitzpatrick RE, Goldman MP. Long-term effectiveness
and side effects of carbon dioxide laser resurfacing for photoaged facial
skin. J Am Acad Dermatol 1999; 40: 401-11.
166. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing.
An evaluation of 500 patients. Dermatol Surg 1998; 24: 315-20.
167. Ruiz-Esparza J, Barba Gomez JM, Gomez de la Torre OL, et al. Ultra-
Pulse laser skin resurfacing in Hispanic patients. A prospective study of
36 individuals. Dermatol Surg 1998; 24: 59-62.
168. Sriprachya-anunt S, Marchell NL, Fitzpatrick RE, et al. Facial resurfacing
in patients with Fitzpatrick skin type IV. Lasers Surg Med 2002; 30:
86-92.
169. West TB, Alster TS. Effect of pretreatment on the incidence of hyperpig-
mentation following cutaneous CO
2
laser resurfacing. Dermatol Surg
1999; 25: 15-17.
170. Haedersdal M, Bech-Thomsen N, Poulsen T, et al. Ultraviolet exposure
infl uences laser-induced wounds, scars, and hyperpigmentation: a
murine study. Plast Reconstr Surg 1998; 101: 1315-22.
171. Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser
skin resurfacing: nonablative, fractional, and ablative laser resurfacing.
J Am Acad Dermatol 2008; 58: 719-37; quiz 38-40.
172. Alster TS. Cutaneous resurfacing with Er: YAG lasers. Dermatol Surg
2000; 26: 73-5.
173. Ratner D, Tse Y, Marchell N, et al. Cutaneous laser resurfacing. J Am
Acad Dermatol 1999; 41: 365-89; quiz 90-2.
174. Khatri KA, Ross V, Grevelink JM, et al. Comparison of erbium: YAG and
carbon dioxide lasers in resurfacing of facial rhytides. Arch Dermatol
1999; 135: 391-7.
175. Goldman MP, Manuskiatti W. Combined laser resurfacing with the 950-
Msec pulsed CO
2
+ Er:YAG lasers. Dermatol Surg 1999; 25: 160-3.
176. Cho SI, Kim YC. Treatment of facial wrinkles with char-free carbon
dioxide laser and erbium: YAG laser. Kor J Dermatol 1999; 37: 177-84.
177. Alster T, Hirsch R. Single-pass CO
2
laser skin resurfacing of light and
dark skin: extended experience with 52 patients. J Cosmet Laser Ther
2003; 5: 39-42.
178. Avram DK, Goldman MP. The safety and effectiveness of single-pass
erbium:YAG laser in the treatment of mild to moderate photodamage.
Dermatol Surg 2004; 30: 1073-6.
179. Ruiz-Esparza J, Barba Gomez JM. Long-term effects of one general pass
laser resurfacing. A look at dermal tightening and skin quality. Dermatol
Surg 1999; 25: 169-73; discussion 74.
180. Kunzi-Rapp K, Dierickx CC, Cambier B, et al. Minimally invasive skin
rejuvenation with Erbium: YAG laser used in thermal mode. Lasers Surg
Med 2006; 38: 899-907.
181. Manuskiatti W, Siriphukpong S, Varothai S, et al. Effect of pulse width
of a variable square pulse (VSP) erbium:YAG laser on the treatment
outcome of periorbital wrinkles in Asians. Int J Dermatol 2010; 49:
200-6.
182. Tanzi EL, Alster TS. Treatment of atrophic facial acne scars with a dual-
mode Er:YAG laser. Dermatol Surg 2002; 28: 551-5.
183. Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S, et al. Treatment
of punched-out atrophic and rolling acne scars in skin phototypes III,
IV, and V with variable square pulse erbium:yttrium-aluminum-garnet
laser resurfacing. Dermatol Surg 2009; 35: 1376-83.
184. Ho C, Nguyen Q, Lowe NJ, et al. Laser resurfacing in pigmented skin.
Dermatol Surg 1995; 21: 1035-7.
185. Kim JW, Lee JO. Skin resurfacing with laser in Asians. Aesthetic Plast
Surg 1997; 21: 115-17.
186. Song MG, Park KB, Lee ES. Resurfacing of facial angiofi bromas in tuber-
ous sclerosis patients using CO
2
laser with fl ashscanner. Dermatol Surg
1999; 25: 970-3.
187. Jeong JT, Kye YC. Resurfacing of pitted facial acne scars with a long-
pulsed Er:YAG laser. Dermatol Surg 2001; 27: 107-10.
188. Kye YC. Resurfacing of pitted facial scars with a pulsed Er:YAG laser.
Dermatol Surg 1997; 23: 880-3.
189. Cho SI, Kim YC. Treatment of atrophic facial scars with combined use of
high-energy pulsed CO
2
laser and Er: YAG laser: a practical guide of laser
techniques for the Er: YAG laser. Dermatol Surg 1999; 25: 959-64.
190. Fitzpatrick RE. Maximizing benefi ts and minimizing risk with CO
2
laser
resurfacing. Dermatol Clin 2002; 20: 77-86.
191. Lowe NJ, Lask G, Griffi n ME. Laser skin resurfacing: pre- and posttreat-
ment guidelines. Dermatol Surg 1995; 21: 1017-19.
